OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 12

From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy
Anqi Lin, Aimin Jiang, Lihaoyun Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 3

Novel clinical trial designs emerging from the molecular reclassification of cancer
Mina Nikanjam, Shumei Kato, Teresa Allen, et al.
CA A Cancer Journal for Clinicians (2025)
Open Access | Times Cited: 3

The gut microbiome and cancer response to immune checkpoint inhibitors
Francesca S. Gazzaniga, Dennis L. Kasper
Journal of Clinical Investigation (2025) Vol. 135, Iss. 3
Open Access | Times Cited: 2

Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis
Xinpei Li, Shijie Shang, Meng Wu, et al.
Cancer Letters (2024) Vol. 598, pp. 217096-217096
Closed Access | Times Cited: 11

Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Cancer Management and Research (2025) Vol. Volume 17, pp. 171-192
Open Access | Times Cited: 1

The gut microbiome and dietary fibres: implications in obesity, cardiometabolic diseases and cancer
Nathalie M. Delzenne, Laure B. Bindels, Audrey M. Neyrinck, et al.
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 6

Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC)
Teresa Del Giudice, Nicoletta Staropoli, Pierfrancesco Tassone, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1806-1806
Open Access | Times Cited: 5

Insights of probiotics as an alternative medicine for cancer therapy, mechanism, and applications
Sourik Mukherjee, Dharmender Kumar, Dipanjan Guha
Medicine in Microecology (2024) Vol. 22, pp. 100111-100111
Open Access | Times Cited: 5

Harnessing Lactobacillus reuteri‐Derived Extracellular Vesicles for Multifaceted Cancer Treatment
Soyeon Yi, Eunkyeong Jung, Hye Ran Kim, et al.
Small (2024)
Open Access | Times Cited: 5

Cancer and microbiome-targeted therapies
Avtar S. Meena, Pratibha Singh, Pradeep K. Shukla
International review of cell and molecular biology (2025)
Closed Access

Unveiling the Interplay Between the Human Microbiome and Gastric Cancer: A Review of the Complex Relationships and Therapeutic Avenues
Jenan Al‐Matouq, Hawra Al-Ghafli, Noura N. Alibrahim, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 226-226
Open Access

Resistance mechanisms to immune checkpoint inhibitors: updated insights
Besan H. Al-Saafeen, Bassam R. Ali, Eyad Elkord
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access

Gut microbiota interact with breast cancer therapeutics to modulate efficacy
Alana A. Arnone, Katherine Ansley, Arielle L. Heeke, et al.
EMBO Molecular Medicine (2025)
Open Access

Clinical Applications of Microbiome in Renal Cell Carcinoma
Salim Elyas, Pedro Barata, Ulka N. Vaishampayan
European Urology Focus (2025)
Closed Access

Enhancing the Immunogenicity of Nivolumab plus Ipilimumab with Live Bacterial Supplementation in Metastatic Renal Cell Carcinoma
Kevin Zarrabi, Ulka N. Vaishampayan, Pedro Barata
European Urology Focus (2025)
Closed Access

Fasting-mimicking diet-enrichedBifidobacterium pseudolongumsuppresses colorectal cancer by inducing memory CD8+T cells
Ke Nan, Ziwen Zhong, Ying Yue, et al.
Gut (2025), pp. gutjnl-333020
Closed Access

Combining gut microbiota modulation and immunotherapy: A promising approach for treating microsatellite stable colorectal cancer
Yujie Chang, Min Long, Hanguo Shan, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 208, pp. 104629-104629
Closed Access

Skin microbiome and dermatologic disorders
Tiffany C. Scharschmidt, Julia A. Segre
Journal of Clinical Investigation (2025) Vol. 135, Iss. 3
Open Access

Linking microbiome to cancer: A mini-review on contemporary advances
Leonard Whye Kit Lim
The Microbe (2025), pp. 100279-100279
Open Access

Current status and future perspectives of immunotherapy for abdominal liposarcoma: From basic research to clinical practice
Aobo Zhuang, Zhe Xi, Ying Cheng, et al.
Shijie huaren xiaohua zazhi (2025) Vol. 33, Iss. 2, pp. 81-88
Open Access

Role of human microbiota in facilitating the metastatic journey of cancer cells
Himisa Shah, Premal H. Patel, Aritro Nath, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access

Page 1 - Next Page

Scroll to top